Product Information
INFED 100 MG/2 ML VIAL is a brand product labeled by Allergan, Inc., priced at $18.8898 per ML under NDC 00023608210. Its NADAC has been published 111 times since Aug 21, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is BP.
Strength
50 mg/mL
Manufacturer
Allergan, Inc.NDC
00023608210
Classification
Brand
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
IRON DEXTRANApproval Type
New Drug (NDA)
FDA Application
NDA017441FDA Approved
Before 1982
TE Code
BP
On Market Since
4/29/1974
Pharmacological Classes
Price Statistics
The NADAC for INFED 100 MG/2 ML VIAL has been published 111 times since Aug 21, 2024, and over the history we have for it it has risen 9.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.8898 per ML |
|---|---|
| All-time high | $18.9002 (Jul 15, 2026) |
| All-time low | $17.2016 (Sep 18, 2024) |
| 52-week high | $18.9002 |
| 52-week low | $18.0002 |
| Median price | $18.0731 |
| Average price | $18.1847 |
| Largest weekly change | +5.0% (Jan 14, 2026) |
| Weeks tracked | 111 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Iron Dextran market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Iron Dextran market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Parenteral Iron Replacement class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of INFED 100 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for INFED 100 MG/2 ML VIAL, manufactured by Allergan, Inc., is $18.8898 per ML (NDC 00023608210), effective Sep 30, 2026.
How has the price of INFED 100 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for INFED 100 MG/2 ML VIAL has risen 9.6%. It has been tracked across 111 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for INFED 100 MG/2 ML VIAL?
Since Aug 21, 2024, the NADAC for INFED 100 MG/2 ML VIAL has ranged from a low of $17.2016 (Sep 18, 2024) to a high of $18.9002 (Jul 15, 2026), with a median of $18.0731 per ML.
Are there cheaper alternatives to INFED 100 MG/2 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of INFED 100 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures INFED 100 MG/2 ML VIAL?
INFED 100 MG/2 ML VIAL (NDC 00023608210) is labeled by Allergan, Inc., and CMS classifies it as a brand product.